• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 ANTIGEN SELF-TEST; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 ANTIGEN SELF-TEST; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195-160
Medical Device Problem Code Delivered as Unsterile Product (1421)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/25/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This investigation is still in progress.Once the investigation is completed, a supplemental report will be provided.
 
Event or Problem Description
The consumer reported that the binaxnow covid-19 antigen self-test swab packaging contained a "hair inside the wrapper." the date of this reported event is unknown.No adverse patient effects were reported.No additional patient information, including treatment and outcome, was provided.
 
Additional Manufacturer Narrative
Correction: h4.Additional: d4.Investigation report: testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 173463 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for kit part number 195-160 / lot 173463 and device part number 195-430h / lot 170543.The lot met the required release specifications.The current overall incident rate for foreign objects for this specific lot 173463 based on the total quantity of kits manufactured for distribution is 0.0003% abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue, however based on the information provided by the customer it appeared related to known potential manufacturing defects.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 ANTIGEN SELF-TEST
Common Device Name
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key13291737
Report Number1221359-2022-00318
Device Sequence Number11823161
Product Code QKP
UDI-Device Identifier00811877011415
UDI-Public01008118770114151722101210173463
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
EUA210264
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date10/12/2022
Device Catalogue Number195-160
Device Lot Number173463
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/25/2021
Supplement Date Received by Manufacturer06/01/2022
Initial Report FDA Received Date01/19/2022
Supplement Report FDA Received Date06/09/2022
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/29/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-